Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00315406 · ClinicalTrials.gov registry record
Determining Disease Activity Biomarkers in Individuals With Polyarteritis Nodosa
A clinical trial, sponsored by University of Pennsylvania.
- Completed
- Registry status
- 107
- Enrollment target
NCT00315406: Completed study, sponsored by University of Pennsylvania.
NCT00315406 is a clinical trial that has completed, run by University of Pennsylvania. The registered enrollment target is 107 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00315406 has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- 107 participants
- Enrollment target
Study Summary
Polyarteritis nodosa (PAN) is a rare immune system disorder that causes swelling and damage to small- and medium-sized blood vessels in the body. In order to properly treat this disease, it is critical that the level of disease activity can be determined over the course of the disease. The purpose of this study is to determine new biological markers, or biomarkers, that may be used to assess the severity of disease in people with PAN.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 107 participants |
| Start Date | 2006-04 |
| Est. Completion | 2019-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00315406
The ClinicalTrials.gov registry entry for NCT00315406 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 107 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00315406 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00315406 about?
NCT00315406 is a clinical study titled "Determining Disease Activity Biomarkers in Individuals With Polyarteritis Nodosa". Polyarteritis nodosa (PAN) is a rare immune system disorder that causes swelling and damage to small- and medium-sized blood vessels in the body. In order to properly treat this disease, it is critical that the level of disease activity can be determined over the course of the disease. The purpose o...
What is the current status of trial NCT00315406?
This trial is currently completed. The enrollment target is 107 participants. The study started on 2006-04. Estimated completion is 2019-12.
Who is sponsoring clinical trial NCT00315406?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.